Stockreport

How Investors May Respond To Rhythm Pharmaceuticals (RYTM) FDA Win For IMCIVREE In Acquired Hypothalamic Obesity [Yahoo! Finance]

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com
PDF with acquired hypothalamic obesity, supported by positive Phase 3 TRANSCEND data in this rare, brain-injury–related form of obesity. At the same time, Rhythm named PAN [Read more]